We've found
10,106 Gastrointestinal
clinical trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroparesis Clinical Trial
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Trial Comparing SOC +Skin IQ MCM vs SOC for Pressure Ulcer (PU)
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function
Status: Enrolling,
Phase
I
Updated: 5/4/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,106 Gastrointestinal
clinical trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 7/27/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 7/27/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Thrombocytopenia Associated With Liver Disease Clinical Trial
Updated: 5/5/2016
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Status: Enrolling,
Phase
III
Updated: 5/5/2016
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 12/12/2016
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling,
Phase
II
Updated: 12/12/2016
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Updated: 12/31/1969
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Updated: 8/12/2015
Trial Comparing SOC +Skin IQ MCM vs SOC for Pressure Ulcer (PU)
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
Updated: 5/4/2016
A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function
Status: Enrolling,
Phase
I
Updated: 5/4/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Updated: 12/31/1969
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials